Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus
Infection of Macaca fascicularis (cynomolgus monkey) with chimeric simian/human immunodeficiency virus (SHIV) provides a valuable experimental animal model of AIDS and is widely used for the development of human immunodeficiency virus vaccine strategies. In these settings, analysis of CD8+ T-cell responses during infection represents one of the key parameters for monitoring the evaluation of containment of virus replication. The generation of Gag-specific CD8+ T cells was reported previously from a cynomolgus monkey infected with SHIV89.6P by taking advantage of a B-lymphoblastoid cell line transduced with a retroviral vector expressing simian immunodeficiency virus (SIV) Gag. Here, it was shown that these cytotoxic T lymphocytes (CTLs) demonstrated specificity for a single 9 aa peptide (NCVGDHQAA) spanning aa 192–200 of the SIVmac239 p55gag protein. Furthermore, a positive response was found against the same epitope in one of six other SHIV-infected monkeys. This newly identified SIV Gag CTL epitope in SHIV-infected cynomolgus monkeys will be a useful tool for monitoring and evaluating Gag-specific immune responses during vaccination and infection in the cynomolgus monkey model of AIDS.
AppayV.,
DunbarP. R.,
CallanM.& 18 other authors2002; Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379–385[CrossRef]
BarouchD. H.,
SantraS.,
SchmitzJ. E.& 26 other authors2000; Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486–492[CrossRef]
BarouchD. H.,
KunstmanJ.,
KurodaM. J.& 11 other authors2002; Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335–339[CrossRef]
DonahoeS. M.,
MorettoW. J.,
SamuelR. V.,
MetznerK. J.,
MarxP. A.,
HankeT.,
ConnorR. I.,
NixonD. F.2000; Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus. Virology 272:347–356[CrossRef]
GauduinM.-C.,
KaurA.,
AhmadS.,
YilmaT.,
LifsonJ. D.,
JohnsonR. P.2004; Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T cell responses in rhesus macaques. J Immunol Methods 288:61–79[CrossRef]
GerettiA.-M.,
HulskotteE. G. J.,
DingsM. E. M.,
van BaalenC. A.,
van AmerongenG.,
OsterhausA. D. M. E.1997; CD8 cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26. J Gen Virol 78:821–824
GoulderP. J. R.,
PhillipR. E.,
ColbertR. A.& 9 other authors1997; Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3:212–217[CrossRef]
HarariA.,
VallelianF.,
MeylanP. R.,
PantaleoG.2005; Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 174:1037–1045[CrossRef]
KurodaM. J.,
SchmitzJ. E.,
BarouchD. H.,
CraiuA.,
AllenT. M.,
SetteA.,
WatkinsD. I.,
FormanM. A.,
LetvinN. L.1998; Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I–peptide complex. J Exp Med 187:1373–1381[CrossRef]
LoffredoJ. T.,
SidneyJ.,
WojewodaC.& 8 other authors2004; Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol 173:5064–5076[CrossRef]
MenssenR.,
OrthP.,
ZieglerA.,
SaengerW.1999; Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J Mol Biol 285:645–653[CrossRef]
MillerM. D.,
YamamotoH.,
HughesA. L.,
WatkinsD. I.,
LetvinN. L.1991; Definition of an epitope and MHC class I molecule recognized by Gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J Immunol 147:320–329
MothéB. R.,
SidneyJ.,
DzurisJ. L.,
LieblM. E.,
FuengerS.,
WatkinsD. I.,
SetteA.2002; Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins. J Immunol 169:210–219[CrossRef]
NegriD. R. M.,
BuffaV.,
LeoneP.& 7 other authors2004; Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. J Immunol Methods 291:153–163[CrossRef]
OggG. S.,
JinX.,
BonhoefferS.& 12 other authors1998; Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103–2106[CrossRef]
PantaleoG.,
KoupR. A.2004; Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 10:806–810[CrossRef]
RobinsonS.,
ChariniW. A.,
NewbergM. H.,
KurodaM. J.,
LordC. I.,
LetvinN. L.2001; A commonly recognized simian immunodeficiency virus nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the pentavalent major histocompatibility complex class I allele Mamu-A*02. J Virol 75:10179–10186[CrossRef]
SchmitzJ. E.,
KurodaM. J.,
SantraS.& 13 other authors1999; Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857–860[CrossRef]
SunY.,
IglesiasE.,
SamriA.,
KamkamidzeG.,
DecovilleT.,
CarcelainG.,
AutranB.2003; A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J Immunol Methods 272:23–34[CrossRef]
UdaA.,
TanabayashiK.,
YamadaY. K.,
AkariH.,
LeeY.-J.,
MukaiR.,
TeraoK.,
YamadaA.2004; Detection of 14 alleles derived from the MHC class I A locus in cynomolgus monkeys. Immunogenetics 56:155–163
UdaA.,
TanabayashiK.,
FujitaO.,
HottaA.,
TeraoK.,
YamadaA.2005; Identification of the MHC class I B locus in cynomolgus monkeys. Immunogenetics 57:189–197[CrossRef]
Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus